Supplementary Materials

The PDF file includes:

• Materials and Methods
• Fig. S1. Characterization of lipoaspirate-derived MSCs in vitro.
• Fig. S2. Inhibition of T cell proliferation by HUCPVC.
• Fig. S3. Characterization of lipoaspirate-derived MSCs in vivo.
• Fig. S4. AUC glucose 6 weeks after transplant.
• Fig. S5. Glucose concentrations after removal of kidney islet graft by nephrectomy.
• Fig. S6. Immunofluorescence analysis with endothelial marker ERG.
• Fig. S7. Vessel density in islet grafts with and without HUCPVCs.
• Fig. S8. Histological assessment of cell infiltrate into liver after syngeneic islet grafts ± HUCPVC.
• Fig. S9. Liver function 6 weeks after transplant.
• Table S1. Human islet preparation and associated clinical characteristics.
• Table S2. GSIS and OCR of islet preparations.
• Table S3. Glucose concentrations and weights before surgery.
• References (64–71)

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

• Data file S1 (Microsoft Excel format). Primary data.